# OnCo record mrg003 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mrg003/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mrg003" ;
  schema:name "MRG003"@en ;
  schema:description "MRG003 is an experimental antibody-drug conjugate from Lepu Biopharma in phase 3 trials for head and neck squamous cell carcinoma and nasopharyngeal carcinoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/mrg003/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=MRG003>, <https://www.lepubiopharma.com> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/nasopharyngeal/> ;
  onco:companies <https://onco.cc/companies/lepu-biopharma/> ;
  onco:trials <https://onco.cc/trials/nct05751512/>, <https://onco.cc/trials/nct06976190/>, <https://onco.cc/trials/nct05126719/> .